Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral AgentsCheng Wang, George Lau, Bing Li et al.|Clinical Gastroenterology and Hepatology|2016Cited by 197
Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World DataGuofeng Chen, George Lau, Lai Wei et al.|PLoS ONE|2016Cited by 44